At the turn of last year the Ladybug shell entered a merger
At the turn of last year the Ladybug shell entered a merger agreement with a mystery company, and they hired on James B. Frack as CEO to oversee the deal.
Mr. Frack is a very well-known and respected merger/acquisition specialist that has done numerous deals throughout his career.
We found out a few months later that it was actually a Chinese merger. Moving forward a few more months, we called Mr. Frack and confirmed the merger. As time progressed we continually chatting with Mr. Frack slowly finding out more and more.
We discovered the Chinese merger is tied to some large economic names in China. We discovered the merging body was Highin; a financial body that helps companies to reach their goals through financial analysis, planning, consultancy, acquisition, and versions other tools. Acquisition is the prime word, as we're aware they predominately operate as a holding firm/parent to develop their own companies.
Dr. Jianhui Huang is the current director/CEO of Highin, and he brings with him over 20 years of economic leadership, having handled responsibility over $10.5 billion throughout his financial career.
The price resurgence is due to the CEO informing us that we're very close to the merger finalizing.
1
Ladybug Resource Grp (LBRG) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
MediaAlpha's Upcoming Financial Report Announcement MediaAlpha, Inc. (NYSE: MAX), based in Los Angeles, has exciting news for its investors and stakeholders. The company is gearing up to announce its financial results for the third quarter of 2024 on an upcoming Wednesday. This announcement will take place after the market closes, providing important insights into the...
Continue Reading
BigID Launches Innovative Solutions for AI Data Access Control Organizations are increasingly leveraging technology in ways that enhance workflows while prioritizing data security. BigID, a leader in the realm of data security and privacy, has introduced a groundbreaking method to prevent unauthorized access to sensitive information in Artificial Intelligence (AI)...
Continue Reading
Latigo Biotherapeutics Secures Major Funding for Pain Relief Advancement Latigo Biotherapeutics, a clinical-stage biotechnology firm dedicated to creating leading non-opioid pain management solutions, has officially closed a substantial $150 million in Series B financing. This funding round aims to push forward the development of their innovative Nav1.8 inhibitor...
Continue Reading
WisdomTree's Strategic Shift in UK Equity Income In a significant move, the Directors of WisdomTree Issuer ICAV have officially announced plans to delist the WisdomTree UK Equity Income UCITS ETF. This decision comes as the company aims to merge its focus towards investing in UK Quality Dividend Growth strategies. The shares of this Sub-Fund will no longer be available...
Continue Reading
Avista Foundation's Generous Grants in 2024 In its recent fourth-quarter granting cycle, the Avista Foundation has showcased its unwavering commitment to enhancing community welfare. The foundation distributed a remarkable total of $54,650 to 21 nonprofit organizations across various initiatives aimed at promoting environmental sustainability and enriching arts and...
Continue Reading